Cargando...
一代与二代酪氨酸激酶抑制剂为基础的方案治疗BCR-ABL阳性急性淋巴细胞白血病疗效比较
OBJECTIVE: To explore the clinical efficacy and prognostic factors of first-generation and second-generation tyrosine kinase inhibitors (TKI) based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia (ALL). METHODS: Retrospectively analyze the clinical characteris...
Gardado en:
| Publicado en: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342448/ https://ncbi.nlm.nih.gov/pubmed/31648474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.09.005 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|